← Open Payments lookup

AIMEE JAQUELYN PEREZ: Open Payments

NPI 1801324892 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,371 in 68 payments from 14 companies in 2025. Trend: 2023 $853 · 2024 $1,594 · 2025 $1,371

Food & beverage: $1,286Education: $85
CompanyPaymentsAmount
Janssen Biotech, Inc.10$305
ABBVIE INC.11$190
Ardelyx, Inc.8$171
Madrigal Pharmaceuticals12$158
GENZYME CORPORATION4$100
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$96
PFIZER INC.4$76
Phathom Pharmaceuticals, Inc.5$76
Takeda Pharmaceuticals U.S.A., Inc.3$62
RedHill Biopharma Inc.1$35

Products named: TREMFYA, IBSRELA, REZDIFFRA, MAVYRET, DUPIXENT, XIFAXAN, XELJANZ, VOQUEZNA.

Industry payments across CA — which companies pay providers there.